Royal Bank of Canada
CTSO icon

Royal Bank of Canada’s Cytosorbents Corp CTSO Stock Holding History

Royal Bank of Canada’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,100
Closed -$1K – 7236
2025
Q3 		$1K Buy
1,100
+300
+38% +$295 ﹤0.01% 6963
2025
Q2 		$1K Buy
+800
New +$803 ﹤0.01% 6866
2024
Q4 		– Sell
-2,000
Closed -$3K – 6938
2024
Q3 		$3K Buy
2,000
+1,508
+307% +$1.65K ﹤0.01% 6586
2024
Q2 		$0 Buy
492
+399
+429% +$346 ﹤0.01% 7126
2024
Q1 		$0 Buy
93
+14
+18% +$14 ﹤0.01% 7093
2023
Q4 		$0 Sell
79
-7,450
-99% -$11.1K ﹤0.01% 7189
2023
Q3 		$14K Buy
7,529
+2,356
+46% +$6.76K ﹤0.01% 6305
2023
Q2 		$19K Buy
5,173
+2,637
+104% +$8.34K ﹤0.01% 6231
2023
Q1 		$8K Sell
2,536
-464
-15% -$1.39K ﹤0.01% 6397
2022
Q4 		$5K Sell
3,000
-3,356
-53% -$4.98K ﹤0.01% 6723
2022
Q3 		$9K Buy
6,356
+1,500
+31% +$2.93K ﹤0.01% 6470
2022
Q2 		$11K Buy
4,856
+1,822
+60% +$4.18K ﹤0.01% 6346
2022
Q1 		$10K Sell
3,034
-10,074
-77% -$36.1K ﹤0.01% 6937
2021
Q4 		$55K Buy
13,108
+3,968
+43% +$22.3K ﹤0.01% 6315
2021
Q3 		$74K Buy
9,140
+1,317
+17% +$10.7K ﹤0.01% 5910
2021
Q2 		$58K Buy
7,823
+840
+12% +$7.08K ﹤0.01% 5937
2021
Q1 		$61K Buy
6,983
+1,111
+19% +$10.6K ﹤0.01% 5767
2020
Q4 		$46K Buy
5,872
+2,713
+86% +$22.7K ﹤0.01% 5688
2020
Q3 		$25K Sell
3,159
-3,320
-51% -$30K ﹤0.01% 5606
2020
Q2 		$64K Sell
6,479
-2,378
-27% -$21.8K ﹤0.01% 5112
2020
Q1 		$68K Buy
8,857
+3,027
+52% +$15.3K ﹤0.01% 4991
2019
Q4 		$22K Buy
5,830
+1,230
+27% +$5.37K ﹤0.01% 5815
2019
Q3 		$24K Buy
4,600
+1,478
+47% +$8.6K ﹤0.01% 5414
2019
Q2 		$21K Sell
3,122
-1,478
-32% -$10.2K ﹤0.01% 5683
2019
Q1 		$35K Sell
4,600
-10
-0.2% -$78 ﹤0.01% 5360
2018
Q4 		$37K Sell
4,610
-1,785
-28% -$17.7K ﹤0.01% 5259
2018
Q3 		$82K Buy
6,395
+1,592
+33% +$20K ﹤0.01% 4969
2018
Q2 		$54K Buy
4,803
+403
+9% +$3.81K ﹤0.01% 5121
2018
Q1 		$31K Sell
4,400
-1,474
-25% -$11.1K ﹤0.01% 5268
2017
Q4 		$38K Buy
5,874
+3,069
+109% +$19.5K ﹤0.01% 5304
2017
Q3 		$17K Buy
2,805
+1,005
+56% +$5.12K ﹤0.01% 6021
2017
Q2 		$8K Sell
1,800
-2,500
-58% -$11K ﹤0.01% 5878
2017
Q1 		$19K Buy
4,300
+1,400
+48% +$7.82K ﹤0.01% 5645
2016
Q4 		$16K Sell
2,900
-600
-17% -$3.29K ﹤0.01% 5877
2016
Q3 		$22K Buy
3,500
+2,700
+338% +$14K ﹤0.01% 5517
2016
Q2 		$4K Hold
800
– – ﹤0.01% 5998
2016
Q1 		$3K Hold
800
– – ﹤0.01% 6038
2015
Q4 		$4K Hold
800
– – ﹤0.01% 6209
2015
Q3 		$5K Hold
800
– – ﹤0.01% 6153
2015
Q2 		$5K Hold
800
– – ﹤0.01% 6238
2015
Q1 		$11K Hold
800
– – ﹤0.01% 5544
2014
Q4 		$8K Buy
+800
New +$7.83K ﹤0.01% 5667

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Royal Bank of Canada's CTSO Position: Q4 2025 in Review

Royal Bank of Canada sold out of Cytosorbents Corp (CTSO) in Q4 2025, closing a stake of 1,100 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in CTSO in Q4 2014 and held it in 42 quarters. The position peaked at $82K in Q3 2018. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

  • Royal Bank of Canada reported no remaining Cytosorbents Corp position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1,100 Cytosorbents Corp shares in Q4 2025, an estimated $1K.
  • Royal Bank of Canada first reported a position in Cytosorbents Corp in Q4 2014 and held it in 42 quarters.
  • Royal Bank of Canada's Cytosorbents Corp position peaked at $82K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.